Company Filing History:
Years Active: 1998
Title: The Innovative Contributions of Marcos Canas Poblet
Introduction
Marcos Canas Poblet is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of peptide synthesis, particularly through his innovative patent related to carbocalcitonin. His work exemplifies the intersection of scientific research and practical application in the pharmaceutical industry.
Latest Patents
Marcos holds a patent for a procedure for obtaining carbocalcitonin. This procedure involves the condensation of fragment 1, a docosapeptide corresponding to the carboxamide end of the carbocalcitonin sequence, which is conveniently protected and anchored on resin. It also includes fragment 2 or 3, a nonapeptide corresponding to the amino end of the salmon calcitonin sequence, featuring a ready-formed cycle between the Asu and Ser residues. The complete peptide skeleton is treated with an acid to free the totally deprotected peptide from the resin. This innovative approach has the potential to enhance the efficacy of peptide-based therapies.
Career Highlights
Marcos Canas Poblet is associated with Lipotec, S.A., a company known for its advancements in cosmetic and pharmaceutical ingredients. His work at Lipotec has allowed him to apply his expertise in peptide synthesis to develop products that can benefit various industries.
Collaborations
Marcos collaborates with talented professionals in his field, including Berta Ponsati Obiols and Gemma Jodas Farres. These collaborations foster a creative environment that encourages innovation and the sharing of ideas.
Conclusion
Marcos Canas Poblet's contributions to the field of peptide synthesis through his patent for carbocalcitonin highlight his role as an influential inventor. His work not only advances scientific knowledge but also has practical implications in the pharmaceutical industry.